All4NutraNo products in the cart.
All4NutraStartseite » Suppliers » Gattefossé » Page 51
This study aimed to systematically compare licochalcone A (LicA) and glabridin (Gla) (whitening agents) release and permeation from Carbomer 940...
Nanocapsules can be equated to other nanovesicular systems in which a drug is entrapped in a void containing liquid core...
The emerging pathogen Candida auris is an emerging fungal pathogen that was associated with nosocomial infectious outbreaks. Its worldwide incidence and the...
Different mucoadhesive systems have been studied in recent years to increase the residence time of the delivery systems and to...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a very poor prognosis. Its treatment is hindered by a lack...
Background Macitentan blocks endothelin receptors in order to control the pulmonary arterial hypertension (PAH). Oral administration of macitentan is associated...
Therapeutic peptides can treat a wide variety of diseases with selective and potent action. Their oral bioavailability is strongly limited...
Augmented reality in oral bioavailability enhancement arena: Labrafac™ MC60, glycerol monocaprylocaprate Gattefossé widens its range of high quality, functional excipients...
This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective...
Lipid-based biphasic microparticles are generally produced by long and complex techniques based on double emulsions. In this study, spray congealing...
Copyright: PharmaExcipients AG